Bachem Holding AG

Global CDMO specializing in peptides and oligonucleotide manufacturing.

Founded 1971 Public Company SIX: BANB
Visit Website

Company Overview

Bachem Holding AG is a Swiss biotechnology and pharmaceutical manufacturing company specializing in peptide and oligonucleotide APIs. It serves pharmaceutical and biotechnology companies worldwide with research, clinical development, and commercial manufacturing services.

Company Information

Company Name Bachem Holding AG
CEO Anne-Kathrin Stoller
Chief Commercial Officer Interim: Anne-Kathrin Stoller
Founded 1971
Founder Peter Grogg
Industry Pharmaceutical Manufacturing (CDMO)
Headquarters Bubendorf, Switzerland
Market Cap Approx. CHF 8–9 Billion
Stock Exchange SIX Swiss Exchange (BANB)
Website www.bachem.com

Products & Services

  • Peptide APIs
  • Oligonucleotide APIs
  • Custom Peptide Synthesis
  • Clinical Manufacturing
  • Commercial Manufacturing
  • Process Development
  • Analytical Services
  • Research Peptides
  • CDMO Services
  • Regulatory Support

Global Locations

  • 🇨🇭 Bubendorf
  • 🇨🇭 Vionnaz
  • 🇺🇸 Vista, CA
  • 🇺🇸 Torrance, CA
  • 🇺🇸 Philadelphia
  • 🇬🇧 St. Helens
  • 🇩🇪 Weil am Rhein
  • 🇯🇵 Tokyo

Latest News

  • Opened new Building K manufacturing facility.
  • Secured CHF 500 million revolving credit facility.
  • Continues expansion of peptide manufacturing capacity.
  • Leadership transition announced for executive committee.

Contact Information

Address Hauptstrasse 144
4416 Bubendorf
Switzerland
Phone +41 58 595 2020
Email info@bachem.com
Website https://www.bachem.com